Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery (scientific article)

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re

Q28594116

Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis

Q33552889

Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes

Q33721729

Tumor necrosis factor: a master-regulator of leukocyte movement

Q33846423

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

Q33909940

Neuroendocrine-immune system interactions and autoimmunity

Q34300053

TNF ligands and receptors--a matter of life and death

Q34542205

TNF receptor subtype signalling: differences and cellular consequences

Q34565473

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

Q36230900

Angiogenic and anti-angiogenic factors in adrenal tumours.

Q36718400

TNF and cancer: the two sides of the coin

Q36992553

Gene trapping identifies a putative tumor suppressor and a new inducer of cell migration

Q39936248

IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages

Q39938350

Tumor necrosis factor for the treatment of malignancies

Q40758699

Cytokine-mediated modulation of integrin, ICAM-1 and CD44 expression on human uveal melanoma cells in vitro

Q41322270

Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences

Q41729888

Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells

Q42487855

Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients

Q43679611

Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection

Q43875898

Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?

Q44558636

Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery.

Q51815265

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

Q51917147

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

Q59074915

Tumor necrosis factor α and interferon γ genes polymorphisms and serum levels in pancreatic adenocarcinoma

Q60609725

Soluble TNF receptors in amniotic fluid and in urine from pregnant women

Q67494265

High concentrations of soluble tumor necrosis factor receptors in ascites

Q67494849

[Secretion of soluble receptors for tumor necrosis factor. An immunologic buffer mechanism during normal pregnancy?]

Q67867547

More insights into the complex physiology of TNF

Q68250388

Human adrenal cells express tumor necrosis factor-alpha messenger ribonucleic acid: evidence for paracrine control of adrenal function

Q71091961

Direct effects of interleukin-6 on human adrenal cells

Q71905735

Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function

Q72810168

Bovine adrenal cells secrete interleukin-6 and tumor necrosis factor in vitro

Q73981137

Tumour necrosis factor: strategies for improving the therapeutic index

Q77448505

P275

Creative Commons Attribution 4.0 International

copyrighted